A PHASE I STUDY OF CHIMERIC ANTIGEN RECEPTORMODIFIED T CELLS DIRECTED AGAINST CD19 IN PATIENTS WITH RELAPSED OR REFRACTORYCD19(+) B CELL LYMPHOMAS: INTERIM ANALYSIS. (June 2017) - Ying, Z.; Xiang, X.; Song, Y.; Ding, N.; Lin, Y.; Zheng, W.; Wang, X.; Lin, N.; Tu, M.; Xie, Y.; Zhang, C.; Liu, W.; et al.